Literature DB >> 30924829

Catalytic asymmetric cycloaddition reactions of enoldiazo compounds.

Kostiantyn O Marichev1, Michael P Doyle.   

Abstract

This review describes catalytic asymmetric cycloaddition reactions of silyl-protected enoldiazo compounds for the construction of highly functionalized carbo- and heterocycles which possess one or more chiral center(s). The enoldiazo compound or its derivative, donor-acceptor cyclopropene, form electrophilic vinylogous metal carbene intermediates that combine stepwise with nucleophilic dipolar reactants to form products from [3 + 1]-, [3 + 2]-, [3 + 3]-, [3 + 4]-, and [3 + 5]-cycloaddition, generally in high yield and with exceptional stereocontrol and regioselectivity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30924829      PMCID: PMC6484446          DOI: 10.1039/c9ob00478e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  79 in total

Review 1.  Asymmetric synthesis of isoquinoline alkaloids.

Authors:  Maria Chrzanowska; Maria D Rozwadowska
Journal:  Chem Rev       Date:  2004-07       Impact factor: 60.622

2.  Highly enantioselective dearomatizing formal [3+3] cycloaddition reactions of N-acyliminopyridinium ylides with electrophilic enol carbene intermediates.

Authors:  Xinfang Xu; Peter Y Zavalij; Michael P Doyle
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-02       Impact factor: 15.336

Review 3.  Application of (4+3) cycloaddition strategies in the synthesis of natural products.

Authors:  Zengsheng Yin; Yun He; Pauline Chiu
Journal:  Chem Soc Rev       Date:  2018-11-26       Impact factor: 54.564

4.  Use of nonfunctionalized enamides and enecarbamates in asymmetric synthesis.

Authors:  Kovuru Gopalaiah; Henri B Kagan
Journal:  Chem Rev       Date:  2011-05-13       Impact factor: 60.622

5.  Catalytic Divergent [3+3]- and [3+2]-Cycloaddition by Discrimination Between Diazo Compounds.

Authors:  Yongming Deng; Lynée A Massey; Yeray A Rodriguez Núñez; Hadi Arman; Michael P Doyle
Journal:  Angew Chem Int Ed Engl       Date:  2017-08-24       Impact factor: 15.336

6.  Enoldiazosulfones for Highly Enantioselective [3 + 3]-Cycloaddition with Nitrones Catalyzed by Copper(I) with Chiral BOX Ligands.

Authors:  Frady G Adly; Kostiantyn O Marichev; Joseph A Jensen; Hadi Arman; Michael P Doyle
Journal:  Org Lett       Date:  2018-12-14       Impact factor: 6.005

7.  Rhodium(II)-Catalyzed Cycloaddition Reactions of Non-classical 1,5-Dipoles for the Formation of Eight-Membered Heterocycles.

Authors:  Dong Jin Lee; Donguk Ko; Eun Jeong Yoo
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-17       Impact factor: 15.336

8.  Rhodium-catalyzed enantioselective vinylogous addition of enol ethers to vinyldiazoacetates.

Authors:  Austin G Smith; Huw M L Davies
Journal:  J Am Chem Soc       Date:  2012-10-29       Impact factor: 15.419

9.  Asymmetric [4 + 3] cycloadditions between vinylcarbenoids and dienes: application to the total synthesis of the natural product (-)-5-epi-vibsanin E.

Authors:  Brett D Schwartz; Justin R Denton; Yajing Lian; Huw M L Davies; Craig M Williams
Journal:  J Am Chem Soc       Date:  2009-06-17       Impact factor: 15.419

10.  Gold-catalyzed [3+3]-annulation of azomethine imines with propargyl esters.

Authors:  Nathan D Shapiro; Yun Shi; F Dean Toste
Journal:  J Am Chem Soc       Date:  2009-08-26       Impact factor: 15.419

View more
  2 in total

Review 1.  Recent Advances in Catalytic Alkyne Transformation via Copper Carbene Intermediates.

Authors:  Kuiyong Dong; Mengting Liu; Xinfang Xu
Journal:  Molecules       Date:  2022-05-11       Impact factor: 4.927

2.  Synthesis of Chiral Tetrasubstituted Azetidines from Donor-Acceptor Azetines via Asymmetric Copper(I)-Catalyzed Imido-Ylide [3+1]-Cycloaddition with Metallo-Enolcarbenes.

Authors:  Kostiantyn O Marichev; Kan Wang; Kuiyong Dong; Nicole Greco; Lynée A Massey; Yongming Deng; Hadi Arman; Michael P Doyle
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-24       Impact factor: 15.336

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.